Senna Plus (Major Pharmaceuticals)
Welcome to the PulseAid listing for the Senna Plus drug offered from Major Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Major Pharmaceuticals |
| NON-PROPRIETARY NAME: | standardized senna concentrate and docusate sodium |
| SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2010-01-14 |
| END MARKETING DATE: | 0000-00-00 |
Senna Plus HUMAN OTC DRUG Details:
| Item Description | Senna Plus from Major Pharmaceuticals |
| LABELER NAME: | Major Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
| START MARKETING DATE: | 2010-01-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0904-6339_9a880e33-65ac-4bd3-8189-c68b67526b38 |
| PRODUCT NDC: | 0904-6339 |
| APPLICATION NUMBER: | |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers:
